NCT01492465View on ClinicalTrials.gov

Single Ascending Dose Trial in Patients With Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

October 31, 2012

Conditions

Diabetes Mellitus

Interventions

DRUG

AMG 876

Ascending single doses of study drug administered SC, with one cohort administered IV

Trial Locations (3)

68154

Research Site, Omaha

78209

Research Site, San Antonio

San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY